Aspirin suppresses chemoresistance and enhances antitumor activity of 5-Fu in 5-Fu-resistant colorectal cancer by abolishing 5-Fu-induced NF-κB activation

DCLK1 promotes epithelial-mesenchymal transition via the PI3K/Akt/NF-κB pathway in colorectal cancer

(2018) Weiying Liu et al.   INTERNATIONAL JOURNAL OF CANCER

miR-206 regulates 5-FU resistance by targeting Bcl-2 in colon cancer cells

(2018) Xiaomin Meng et al.   OncoTargets and Therapy

Aspirin inhibited the metastasis of colon cancer cells by inhibiting the expression of toll-like receptor 4

(2018) Suaka Kagbo-Kue et al.   Cell and Bioscience

NF-κB activation is an early event of changes in gene regulation for acquiring drug resistance in human adenocarcinoma PC-9 cells

(2018) Masashi Fukuoka et al.   PLoS One

Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy

(2017) Akane Inoue-Yamauchi et al.   Nature Communications

Zinc finger protein 91 (ZFP91) activates HIF-1α via NF-κB/p65 to promote proliferation and tumorigenesis of colon cancer

(2016) Juan Ma et al.   Oncotarget

Aspirin as a neoadjuvant agent during preoperative chemoradiation for rectal cancer

(2015) Angelo Restivo et al.   BRITISH JOURNAL OF CANCER

Aspirin Suppresses the Growth and Metastasis of Osteosarcoma through the NF- B Pathway

(2015) D. Liao et al.   CLINICAL CANCER RESEARCH

NF-κB Expression and Outcomes in Solid Tumors

(2015) Dang Wu et al.   MEDICINE

Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation

(2015) A E S Simões et al.   Cell Death & Disease

Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer

(2015) Yiyao Zhang et al.   Oncotarget

Aspirin in gastrointestinal oncology

(2014) Ruth E. Langley et al.   CURRENT OPINION IN ONCOLOGY

Effect of PET Before Liver Resection on Surgical Management for Colorectal Adenocarcinoma Metastases

(2014) Carol-Anne Moulton et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Anti-VEGF antibody therapy induces tumor hypoxia and stanniocalcin 2 expression and potentiates growth of human colon cancer xenografts

(2013) Shinichiro Miyazaki et al.   INTERNATIONAL JOURNAL OF CANCER

The complexity of NF-κB signaling in inflammation and cancer

(2013) Bastian Hoesel et al.   Molecular Cancer

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials

(2012) Annemijn M Algra et al.   LANCET ONCOLOGY

Potential Role of Salicylates in Type 2 Diabetes

(2010) Martha M Rumore et al.   ANNALS OF PHARMACOTHERAPY

5-Fluorouracil-based chemotherapy for colorectal cancer and MTHFR/MTRR genotypes

(2010) Barbara Pardini et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

NF-κB Signaling Pathway, Inflammation and Colorectal Cancer

(2010) Soly Wang et al.   Cellular & Molecular Immunology

Pharmacogenetic Assessment of Toxicity and Outcome in Patients With Metastatic Colorectal Cancer Treated With LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05

(2010) Valérie Boige et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

(2010) Peter M Rothwell et al.   LANCET

Cycling D1 negatively regulates the expression of differentiation genes in HT-29 M6 mucus-secreting colon cancer cells

(2009) Clara Mayo et al.   CANCER LETTERS

Transforming Growth Factor   Induces Apoptosis through Repressing the Phosphoinositide 3-Kinase/AKT/Survivin Pathway in Colon Cancer Cells

(2008) J. Wang et al.   CANCER RESEARCH

Sulforaphane targets pancreatic tumour-initiating cells by NF- B-induced antiapoptotic signalling

(2008) G Kallifatidis et al.   GUT